Solace is a medical device company that researches and develops non-surgical devices for the treatment of Stress Urinary Incontinence... Read more
Solace is a medical device company that researches and develops non-surgical devices for the treatment of Stress Urinary Incontinence... Read more
News
Apr 21, 2021
MarketScreener
Solace Therapeutics: Solace Therapeutics Announces that Tri Valley Urology Enrolls First Patient in US Pivotal Clinical Trial, using New Office-Based Treatment for Female Stress Urinary Incontinence(SUI).
Mar 30, 2021
Business Wire
Press Release: Solace Therapeutics : Solace Therapeutics Announces that Women and Infants Hospital, Providence, Rhode Island, Enrolls First Patient in United States Pivotal Clinical Trial, using New Office-Based Treatment for Female Stress Urinary Incontinence (SUI)
Mar 22, 2021
BioSpace
Solace Therapeutics: Solace Therapeutics Announces That Scripps Health Enrolls First Patient in US Pivotal Clinical Trial, Using New Office-Based Treatment for Female Stress Urinary Incontinence(SUI)
Mar 02, 2021
The Business Journals: Boston
Solace Therapeutics: Solace Therapeutics, a Framingham-based medical device company focused on bladder disorders, raised $2.5M in equity in a $17.6M funding round, per an SEC filing.
Dec 01, 2020
Business Wire
Press Release: Solace Therapeutics, Inc. : Solace Therapeutics Announces that Regional Urology Enrolls First Patient in US Pivotal Clinical Trial, using New Office-Based Treatment for Female Stress Urinary Incontinence(SUI)
Nov 23, 2020
MarketScreener
Solace Therapeutics, Inc.: Solace Therapeutics : Announces that Urology of Virginia Enrolls First Patient in US Pivotal Clinical Trial, using New Office-Based Treatment for Female Stress Urinary Incontinence(SUI).
Nov 16, 2020
Business Wire
Press Release: Solace Therapeutics, Inc. : Solace Therapeutics Announces that Florida Urology Partners Enrolls First Patient in US Pivotal Clinical Trial, using New Office-Based Treatment for Female Stress Urinary Incontinence(SUI)
Nov 11, 2020
Medical Device News Magazine
Solace Therapeutics, Inc.: WomanCare Enrolls 1st Patient in US Pivotal Clinical Trial, Using New Office-Based Treatment for Female SUI*
Jan 30, 2020
SEC
Solace: Solace Received $4M in Equity Funding
Mar 01, 2017
MassDevice
Solace: Solace Therapeutics says 3rd trial of Vesair bladder device met endpoints
Solace Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10